Silence Therapeutics

is an England-based biotechnology company that develops RNA therapies for the treatment of cardiovascular, renal, metabolic and respiratory diseases...
Read more
Silence Therapeutics President & CEO: Craig Tooman

President & CEO

Craig Tooman

CEO Approval Rating

82/100

Annual Revenue
$43.3M
Employees
116
Funding
$172.9M

Silence Therapeutics Competitors

1Alnylam
2Harness Therapeutics
3Causeway Therapeutics
4Viridian
5Arbutus Biopharma
6Arrowhead
7Dicerna
8Phio Pharmaceuticals
9Benitec Biopharma
10Sylentis

Trending Companies